By Keith Bishop — Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Integrative Oncology Educator, Founder of Prevail Over Cancer
|
IMPORTANT — Please Read This article is educational and is not medical advice, diagnosis, or treatment. It does not replace your oncology team. These statements have not been evaluated by the Food and Drug Administration; nothing here is intended to diagnose, treat, cure, or prevent any disease. No dosing is provided. Integrative strategies are meant to complement — never replace — conventional cancer care. Always review any food, supplement, or medication decision with your physician and pharmacist, especially during active treatment. |
Â
Deep inside nearly every cell in your body sits a single protein that ...
A clinical nutritionist's review of mechanisms — including p53 reactivation, microtubule disruption, glycolysis inhibition, and immune synergy — for two of the most-discussed repurposed antiparasitics in integrative oncology.
Researched and written by Keith Bishop, Integrative Cancer Educator, Cancer Coach, Clinical Nutritionist, Retired Pharmacist, and Founder of Prevail Over Cancer.
You've heard the names. A friend mentioned them. A YouTube video swore by them. A Facebook group of 100,000 members says they cured stage IV cancer. And your oncologist either rolled their eyes or warned you against them.
So what is actually true about fenbendazole and ivermectin in cancer care?
After three decades as a pharmacist and now as a clinical nutritionist and cancer coach working with patients every day, I want to walk you through what the published research actually shows — the mechanisms, the preclinical data, th...